Regenerative Plastic Surgery

$95.00

Pietro Gentile, MD, PhD (Author) – University of “Tor Vergata”, Rome, Italy; Technical Consultant of the Ordinary Court of Rome, Rome, Italy

Series: Plastic and Reconstructive Surgery
BISAC: MED085030

Regenerating damaged organs and tissues, an act that once was considered magic, is currently entrusted to the surgeons who have allowed us to move from replacement and reconstructive plastic surgery to regenerative plastic surgery, through autologous and allogeneic cell-based therapies and growth factors.
The enthusiasm for regenerative plastic surgery and for the treatment of some pathologies addressed by it, such as breast reconstruction, hemifacial atrophy, burns, scars, and aesthetic improvements such as breast and buttock augmentation, face rejuvenation and hair regrowth, has led the author, Professor Pietro Gentile, to rigorously investigate the possible new minimally invasive strategies based on adipose-derived stem cells, human follicle stem cells and growth factors contained in platelet-rich plasma.
This book reports on the latest knowledge regarding the treatment of soft and bone tissue defects.
Therefore, the goal of this text is to introduce and definitively establish this new and interesting field of plastic surgery, called regenerative plastic surgery.

Clear

Details

Table of Contents

Preface

Acknowledgments

Chapter 1. Application of Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery

Chapter 2. Application of Fat Graft in Regenerative Plastic Surgery

Chapter 3. Autologous Platelet-Rich Plasma (A-PRP): Clinical Use of Activated or Not-Activated A-PRP in Androgenetic Alopecia (AGA)

Chapter 4. Clinical Use of Autologous Human Adipose Tissue-Derived Hair Follicle Stem Cells (HAD-HFSCS) in Androgenetic Alopecia

Chapter 5. Clinical Use of Autologous Fluid Cartilage as Biomaterial in the Treatment of Minor Nose Defects

Chapter 6. Gluteal Augmentation Using Autologous Fat Grafting

Chapter 7. Application of Fat Graft Enhanced with Platelet-Rich Plasma and/or Adipose-Derived Stem Cells in Outcomes of Scars

Chapter 8. Biomaterials, Growth Factors and Stem Cell Therapy in Wound Healing

Chapter 9. Stromal Vascular Fraction (SVF) and Adipose-Derived Mesenchymal Stem Cells (AD-MSCS) as a Potential, Safe and Effective Therapy in Combating Coronavirus Disease 2019 (COVID-19)

Chapter 10. FDA and European Rules Regarding Use of Adipose Derived-Stem Cells (ASCS), Human Follicle Mesenchymal Stem Cells (HF-MSCS) and Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery

Index

Additional information

Binding

,